A new report reveals that federal health regulators are considering tough new regulations for surgical mesh used to treat pelvic organ prolapse (POP), which has been linked to thousands of serious injuries and complications.
RECOMMENDATIONS FOR HEALTH CARE PROVIDERS
The FDA encourages health care providers to:
CONSIDERATION OF REGULATORY CHANGES
The FDA is considering regulatory changes that may improve our understanding of the safety and effectiveness of this device. Considerations include:
On September 8-9, 2011, the FDA will convene a meeting of the Obstetrics-Gynecology Devices Panel of the Medical Devices Advisory Committee to discuss the safety and effectiveness of transvaginal placement of mesh for POP and SUI procedures.
Obstetrics and Gynecology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
Reaching out to a lawyer is the first step on your path towards recovering a better quality of life. At Levin Simes Abrams, we give our undivided attention to each client, and all communications are held in the strictest of confidence. We are on hand to guide you through the process and support you at every step of the way. Contact us by filling out the form or calling us directly at (415) 426-3000.
1700 Montgomery Street,
Suite 250 San Francisco,
Phone: (415) 426-3000
Fax: (415) 426-3001